Kaitai Capital

Developer of clinical-stage biopharmaceutical company intended to find treatments for allergies and diseases with high unmet medical needs and considerable commercial potential. The company is building a pipeline for immunotherapy of allergies, autoimmune diseases, and other disorders through internal development and external partnering, enabling accelerating new treatment development.

Apache DolphinScheduler is a distributed and extensible workflow scheduler platform with powerful DAG visual interfaces.

Yiwise Technology Limited designs and develops an artificial intelligence based question and answer system. The company was founded in 2017 and is based in Hangzhou, China.

Yiwise Technology Limited designs and develops an artificial intelligence based question and answer system. The company was founded in 2017 and is based in Hangzhou, China.

Worktile Inc. is a project management software company based in Beijing, China, with additional offices in Shanghai, Shenzhen, and Xi'an. Founded in 2013, the company provides a web and mobile-based platform designed to enhance collaboration and productivity among developers and professionals. By focusing on tools that facilitate teamwork, Worktile aims to improve overall team efficiency in various business environments.

Pleryon Therapeutics is a company focused on advancing drug delivery systems to enhance the standard of living globally. By leveraging its proprietary platform, Pleryon develops innovative drug delivery technologies that cater to a wide range of molecules and therapeutic areas. This approach not only facilitates new drug discovery but also aims to provide patients with access to effective treatments across various medical conditions. The company's commitment to improving healthcare outcomes is reflected in its dedication to creating advanced solutions in drug delivery.

GluBio Pharmaceutical focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

TaoCloud is a provider of software-defined storage solutions that focuses on distributed data storage and management for enterprise-level customers. The company offers a range of products that facilitate software definition, localization, and efficient data storage and management. By streamlining these processes, TaoCloud enables enterprises to utilize their data storage systems more effectively, enhancing operational efficiency and ease of use.

Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., founded in 2012 and located in Zhengjiawu, China, specializes in researching and developing innovative drugs for metabolic diseases and breast cancer. The company focuses on addressing conditions such as Non-Alcoholic SteatoHepatitis (NASH), gout, diabetes, and colon cancers. By concentrating on metabolism and inflammation, Atom Bioscience aims to provide more effective treatment options for patients suffering from these ailments, enhancing the quality of care in the healthcare sector.

Ceram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.

West Lake Xinchen is an AI psychological service technology company, committed to creating an inclusive, scientific, intelligent and professional AI psychological service platform, and insisting on providing customers with scientific and rigorous psychological services.

CirCode utilizes mRNA biotechnology to develop new biomedicine and drugs.

Zhinian Technology is a big data solution provider that develops a system with a memory-based distributed database & computing framework. The system also provides a complete set of big data process services including vector-based programming language, data query, cleaning, analysis, modeling, and visualization.

Redesign Science Inc is a biotechnology company based in New York, established in 2017, that specializes in small molecule drug discovery. The company employs advanced techniques, including first-principles physics and artificial intelligence, to simulate protein targets at the atomic level. This approach allows Redesign Science to identify subtle drug opportunities that conventional computational models may overlook. By focusing on the development of first-in-class small molecules, the company aims to address emerging and challenging targets associated with significant unmet medical needs. Their innovative methodologies not only enhance the understanding of biological pathways and disease mechanisms but also drive the commercialization of new therapeutic solutions.

BioBin Data Science is a new agricultural high-tech enterprise that engages in research and development management in the fields of bioinformatics and plant breeding. They created a variety of products, including breeding software, hardware, data analysis, custom development, and strategic design.

MingSight Pharmaceuticals is focused on developing innovative ophthalmic drugs, particularly targeting diabetic retinopathy and related conditions. The company is conducting a clinical trial for its novel drug, MS-553, which represents the first clinical evaluation of this treatment for diabetic retinopathy. MS-553 is a highly selective protein kinase C (PKC) inhibitor that can be administered orally, offering a less invasive alternative to traditional intraocular injections, which can pose safety risks. In addition to its applications in diabetic retinopathy, MS-553 has shown promise in treating chronic lymphocytic leukemia (CLL) and diabetic macular edema (DME), demonstrating significant efficacy and market potential. The drug can be used alone or in combination with existing therapies, addressing specific mutations in patients and improving treatment outcomes.

Axbio Inc. is a biotechnology company based in Shenzhen, China, specializing in the development and manufacturing of advanced genetic sequencing technology and diagnostic equipment. Founded in 2016, the company offers a variety of genome extraction kits, including those for stool, blood, saliva, and bacteria. Axbio's product line also encompasses sequencing and diagnostic systems, disposable biochips, and reagents. The company employs semiconductor nanotechnology in its biochips for rapid molecular in-vitro diagnostics and utilizes a microfluidic Bio-CMOS platform for high-throughput sequencing. Axbio's capabilities extend from low-cost handheld devices for bedside diagnostics to fully automated instruments suitable for independent laboratories and hospitals, facilitating services such as early cancer screening, rapid pathogen detection, and drug development. The company is currently operating in stealth mode.

Developer of a cloud platform designed for manufacturing industry and provider of factory construction consultation services and production equipment installation services. The company's platform utilizes artificial intelligence, big data, and block chain technologies to establish a full-process supply chain in the manufacturing industry, providing manufacturers with intelligent solutions and flexible production systems.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology. Its proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glue to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Its lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. It was founded in 2018 and is headquartered in Cambridge, Massachusetts.

BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.

PackGene Biotech, LLC develops viral vectors for gene therapies. The company offers adeno-associated virus (AAV) vector cloning/packaging services. PackGene Biotech, LLC is based in the United States.

Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.

Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Developer of clinical-stage biopharmaceutical company intended to find treatments for allergies and diseases with high unmet medical needs and considerable commercial potential. The company is building a pipeline for immunotherapy of allergies, autoimmune diseases, and other disorders through internal development and external partnering, enabling accelerating new treatment development.

ONL Therapeutics, Inc. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing innovative therapies aimed at protecting vision by targeting photoreceptors. Established in 2006, the company specializes in creating photoreceptor protective agents that address the FAS apoptotic pathway, which is critical for preserving photoreceptor cells. With a growing market for retinal drugs exceeding $7 billion, ONL Therapeutics aims to overcome the limitations of existing treatments that do not target the initial neural component of vision loss. The company’s drug programs include small-molecule peptides designed to protect photoreceptors during vision-threatening conditions such as retinal detachment, ultimately enhancing patient outcomes and supporting successful surgical interventions.

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

OncoImmune is a clinical-stage biopharmaceutical company that engages in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. It has completed a Phase II clinical trial of CD24Fc for the prophylactic treatment of acute Graft versus Host Disease for leukemia patients undergoing hematopoietic stem cell transplantation and is poised to launch a pivotal trial for the indication. Oncolmmune was founded in 2000 and is based in Rockville, Maryland.

Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., founded in 2012 and located in Zhengjiawu, China, specializes in researching and developing innovative drugs for metabolic diseases and breast cancer. The company focuses on addressing conditions such as Non-Alcoholic SteatoHepatitis (NASH), gout, diabetes, and colon cancers. By concentrating on metabolism and inflammation, Atom Bioscience aims to provide more effective treatment options for patients suffering from these ailments, enhancing the quality of care in the healthcare sector.

LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology. Its proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glue to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Its lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. It was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010 and headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris focuses on innovative therapies within the oncology sector and is dedicated to combating the challenges posed by drug-resistant pathogens.

Nanjing F&S Pharmatech Co., Ltd. is a pharmaceutical technology company established in 2015 and located in Nanjing, China. The company specializes in providing pharmaceutical intermediates and differentiated active pharmaceutical ingredients (APIs), along with contract manufacturing organization (CMO) services. F&S Pharmatech focuses on the research and development of advanced pharmaceutical chemicals and intermediates, including sacubitril and diphenyl piperidine methanol. By offering intellectual property solutions and environmentally friendly chemical technology, the company aims to support customers in the healthcare industry, particularly research and development centers and generic drug developers, in shortening development cycles and reducing product costs.

Amphivena Therapeutics is a clinical-stage immuno-oncology company focused on developing bifunctional antibody therapies aimed at treating hematologic malignancies. Founded in 2012 and based in South San Francisco, California, the company utilizes its proprietary ReSTORE platform to create dual-action biologics that enhance the patient's immune response against cancer. These therapies are designed to relieve immune suppression while activating T cells, thereby promoting the destruction of tumor cells and their precursors. The platform emphasizes avidity, target selectivity, and safety, and can be engineered to include additional functionalities for targeting solid tumors. As a subsidiary of Affimed N.V., Amphivena Therapeutics aims to provide innovative treatment options for patients facing blood cancers.

Forkhead BioTherapeutics Inc develops oral therapy to treat insulin-dependent diabetes. The company offers Foxin, an oral agent which helps in targeted deletion of FOXO1 protein that restores normal insulin production and normalizes glucose metabolism. The company was incorporated in 2017 and is based in New York, New York.

Sorghum Pharmaceuticals develops small molecule targeted innovative drugs for the unmet medical needs of autoimmune diseases and tumors. In the direction of unmet medical needs in autoimmune diseases and tumors, Gaochun Pharmaceuticals is committed to creating innovative product lines with global competitive advantages by leveraging its distinctive pharmaceutical, biological and clinical capabilities.

LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Zhejiang Daoer Biotechnology Co., Ltd. is a scientific research biopharmaceutical company based in the Xiasha Economic Development Zone of Hangzhou, Zhejiang Province. The company specializes in the development and research of protein drugs aimed at treating metabolic diseases, ophthalmological conditions, and cancer. Utilizing an innovative platform known as xLONGylation, which is a recombinant PEG-like polypeptide, Doer Biologics enhances drug targeting and safety. This advanced technology also supports the creation of activated antibodies for precision tumor therapy and multi-targeted biotherapeutics, facilitating the design of effective treatments for various diseases.

Wangbaoba is a oatmeal brand, and consumers can buy it through some shopping platforms

Abcuro, Inc. is focused on developing immunotherapies aimed at treating autoimmunity and cancer. Incorporated in 2015 and based in Newton, Massachusetts, the company specializes in creating therapeutic antibodies that target novel aspects of the immune system. By employing advanced bioinformatics and analyzing transcription data from human diseases, Abcuro identifies new therapeutic targets and validates them through ex-vivo studies in diseased tissues. This innovative approach aims to enhance treatment strategies and improve patient outcomes in the fields of autoimmunity and oncology.

JeniVision Inc. is a biopharmaceutical company based in Irvine, California, that focuses on discovering advanced therapies for eye and skin diseases. Incorporated in 2014, the company is committed to developing next-generation treatments aimed at improving patient outcomes in these specialized areas of healthcare.

Nanjing F&S Pharmatech Co., Ltd. is a pharmaceutical technology company established in 2015 and located in Nanjing, China. The company specializes in providing pharmaceutical intermediates and differentiated active pharmaceutical ingredients (APIs), along with contract manufacturing organization (CMO) services. F&S Pharmatech focuses on the research and development of advanced pharmaceutical chemicals and intermediates, including sacubitril and diphenyl piperidine methanol. By offering intellectual property solutions and environmentally friendly chemical technology, the company aims to support customers in the healthcare industry, particularly research and development centers and generic drug developers, in shortening development cycles and reducing product costs.

Imperial Vision Technology develops an artificial intelligence technology which uses machine learning techniques to perform deep compression of images and videos. The product includes image super-resolution IVimageSR which can reconstruct high resolution images from low resolution ones. The product is used in many fields including video live streaming platforms, online video platforms, news app, social network, E-commerce app, game, film, and embedded terminals such as surveillance cameras, smart TV, and IPTV settop box. Imperial Vision Technology was founded in 2016 and is headquartered in Fuzhou, China.

Founded in Hangzhou and headquartered in Hong Kong, China, Weijian Pharmaceuticals is a new pharmaceutical company that promotes the development of China's pharmaceutical health industry. We are committed to bringing the world's leading health products and medical technologies to the Chinese market, providing more advanced treatments for healthcare professionals. And medical information dissemination channels; provide patients with more treatment and rehabilitation resources. Since its establishment in 2006 , they have always adhered to corporate tenet of “ maintaining life and health, enjoying the peace of life ” and adhering to the core values ​​of “ integrity, intention and innovation ” . After years of unremitting efforts, they have developed into a perfect market in the country. A company that provides services such as registration, import, distribution, and promotion of pharmaceuticals and medical devices.

ForDearMe is a E-commerce Start up Based in Hangzhou.

Tekeluo Biotech is a Healthcare company.

A Healthcare Company based in Nanjing,China.

Avenue Zhichuang focuses on the research and development of security robots.

LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.

Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010 and headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris focuses on innovative therapies within the oncology sector and is dedicated to combating the challenges posed by drug-resistant pathogens.

Sanbo Brain Hospital, established in 2004 and based in Beijing, China, operates as a private medical facility specializing in neurology and related fields. The hospital offers a wide range of services, including neurosurgery, neurology, anesthesiology, and pain management, as well as facilities for intensive care, imaging, pathology, cerebrovascular medicine, neuro-ophthalmology, neurophysiology, and neuropsychology. In addition to its primary location, the hospital operates a network of branches across several cities, including Chongqing, Kunming, Fuzhou, and Jinan. Sanbo Brain Hospital is committed to advancing medical expertise through education and research, having organized numerous academic conferences and training programs that have benefitted thousands of medical professionals in the field.

New Tranx Information Technology is a Chinese artificial intelligence-powered translation company. Its products include online instant translation, computer-assisted translation, and localization services for web portals, present with translation capabilities in 37 languages.

DengTa Financial Information Co., Ltd. develops decision support software for stock investment applications. The company's software analyzes securities in stock markets and provides recommendations for investment. Its software is available across mobile formats and television. DengTa Financial Information Co., Ltd. was founded in 2015 and is based in Wuhan, China.

Niuniuqiche is an e-commerce platform for new car transaction based in Shanghai, Shanghai, China.

Astrocyte Pharmaceuticals Inc. is a privately held drug development company based in Cambridge, Massachusetts, focused on creating neuroprotection therapies for various brain injuries, including traumatic brain injuries (TBI), concussions, acute ischemic stroke, and neurodegenerative disorders like Alzheimer’s disease. Incorporated in 2014, the company is advancing its lead product, AST-004, a novel small molecule designed for acute administration. This therapy aims to protect and repair damaged neurons by selectively stimulating astrocytes, a type of brain cell crucial for neuronal health. Astrocyte Pharmaceuticals is dedicated to demonstrating the neuroprotective benefits of its approach and improving outcomes for patients suffering from brain injuries.

Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., founded in 2012 and located in Zhengjiawu, China, specializes in researching and developing innovative drugs for metabolic diseases and breast cancer. The company focuses on addressing conditions such as Non-Alcoholic SteatoHepatitis (NASH), gout, diabetes, and colon cancers. By concentrating on metabolism and inflammation, Atom Bioscience aims to provide more effective treatment options for patients suffering from these ailments, enhancing the quality of care in the healthcare sector.

Operator of a cancer clinical research data management platform. The company improve the efficiency of cancer treatment, drug development, and genetic research through big data on oncology medicine, providing clinical institutions or individuals with customized data management and analysis platform.

Momfo is a financial services provider specializing in real estate lease securitization and short-term financing solutions. The company aims to lower the barriers to real estate investment while offering high-quality financial products. Through its platform, Magic House Po, Momfo sources capital specifically for home renovation projects, including remodeling, furnishing, and purchasing materials. This support enables real estate companies, hotels, and landlords to enhance property utilization and improve overall investment returns.

Beijing Quku Technology Co., Ltd. offers game content creation services. The company was founded in 2015 and is based in Beijing, China.

CARsgen Therapeutics, Ltd., a clinical-stage immunotherapy company, develops and commercializes chimeric antigen receptor T-cell (CAR-T) therapeutics for treating cancers. It offers CAR-T Technology that directs T cells to recognize cancer cells based on expression of specific cell surface proteins to treat solid and hematologic tumors. The company’s CAR-T cells target the GPC3 receptor for the treatment of late-stage hepatocellular carcinoma (HCC, or liver cancer) and lung squamous cell carcinoma (a common type of lung cancer). CARsgen Therapeutics, Ltd. is based in Shanghai, China.

Operator of a financial intermediary platform designed to offer credit evaluation and lending services. The company's platform leverages big data technology to provide financial institute with credit records and evaluation services and also offers lending service to enterprises, enabling clients to efficiently borrow working capital and reduce borrowing costs.

QY Node Informatics Co., Ltd. is a Beijing-based company that specializes in the development and operation of a biological information analysis platform tailored for scientists and clinical researchers. The company provides a comprehensive online genetic big data platform that facilitates the exploration of genomic data, management of analysis pipelines, and integration of medical record and physiological data. By offering tools that enhance research capabilities in the life sciences, QY Node aims to support clients in conducting more effective and informed studies.

Hangzhou Zdjoys Technology Co., Ltd develops mobile games. The company was founded in 2013 and is based in Hangzhou, China.

BeiJing BoYiChuangWei Digital Media Co., Ltd provides digital content services to mobile users. The company was founded in 2006 and is based in Beijing, China.

Zocai Jewelry Co. Ltd. operates jewelry business to consumer websites. Zocai Jewelry Co. Ltd. was 2004 and is based in Shenzhen, China.